home / stock / mbot / mbot quote
Last: | $0.9985 |
---|---|
Change Percent: | 2.08% |
Open: | $0.94 |
Close: | $0.9985 |
High: | $1 |
Low: | $0.9302 |
Volume: | 67,452 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.9985 | $0.94 | $0.9985 | $1 | $0.9302 | 67,452 | 05-02-2024 |
$0.96 | $0.935 | $0.96 | $0.99 | $0.92 | 76,658 | 05-01-2024 |
$0.9225 | $0.9411 | $0.9225 | $0.95 | $0.92 | 47,710 | 04-30-2024 |
$0.949 | $0.8886 | $0.949 | $1.01 | $0.8801 | 360,467 | 04-29-2024 |
$0.88 | $0.87 | $0.88 | $0.889 | $0.861 | 31,899 | 04-26-2024 |
$0.8632 | $0.87 | $0.8632 | $0.9099 | $0.863 | 74,549 | 04-25-2024 |
$0.891 | $0.9 | $0.891 | $0.9 | $0.865 | 79,556 | 04-24-2024 |
$0.8799 | $0.865 | $0.8799 | $0.9 | $0.865 | 88,511 | 04-23-2024 |
$0.8875 | $0.891 | $0.8875 | $0.9 | $0.866 | 125,298 | 04-22-2024 |
$0.865 | $0.8875 | $0.865 | $0.8875 | $0.8618 | 94,884 | 04-19-2024 |
$0.89 | $0.885 | $0.89 | $0.9497 | $0.8601 | 211,787 | 04-18-2024 |
$0.9 | $0.94 | $0.9 | $0.9525 | $0.8815 | 237,867 | 04-17-2024 |
$0.9488 | $1.03 | $0.9488 | $1.05 | $0.93 | 254,445 | 04-16-2024 |
$1.03 | $1.06 | $1.03 | $1.1 | $1.01 | 179,780 | 04-15-2024 |
$1.01 | $1.1 | $1.01 | $1.1 | $1.01 | 128,648 | 04-12-2024 |
$1.08 | $1.14 | $1.08 | $1.14 | $1.06 | 131,810 | 04-11-2024 |
$1.11 | $1.14 | $1.11 | $1.14 | $1.09 | 75,463 | 04-10-2024 |
$1.13 | $1.18 | $1.13 | $1.18 | $1.1 | 145,758 | 04-09-2024 |
$1.17 | $1.21 | $1.17 | $1.24 | $1.16 | 63,866 | 04-08-2024 |
$1.23 | $1.24 | $1.23 | $1.26 | $1.21 | 73,840 | 04-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Microbot Medical Inc. Company Name:
MBOT Stock Symbol:
NASDAQ Market:
Microbot Medical Inc. Website:
BRAINTREE, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today reports that the first phase of the previously announced collaboration with Corewell Health has been completed, which de...
All Regulatory, Clinical, Operational and Pre-Commercial Activities Continue to Stay on Track Despite the On-going Situation in Israel Company Believes that Both Regulatory and Commercial Milestones to be Achieved in Accordance with the Company’s Current Timeline BRAINTREE,...
BRAINTREE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the LIBERTY ® Endovascular Robotic Surgical System, announced that it has filed an Investigational Device Exemption (IDE) application with the US Food and Drug Administration (FDA). The...